We are live on ! Find out more
YMRC

Yorktown Management & Research Company Portfolio holdings

AUM $163M
1-Year Est. Return 68.53%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+68.53%
3 Year Est. Return
+222.75%
5 Year Est. Return
+299.09%
10 Year Est. Return
+935.04%
AUM
$104M
AUM Growth
+$6.43M
Cap. Flow
+$4.73M
Cap. Flow %
4.54%
Top 10 Hldgs %
12.8%
Holding
225
New
31
Increased
7
Reduced
4
Closed
21

Top Buys

Rank Stock Value
1
HWKN icon
Hawkins
HWKN
+$650K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$564K
3
GENI icon
Genius Sports
GENI
+$523K
4
IBKR icon
Interactive Brokers
IBKR
+$522K
5
INTA icon
Intapp
INTA
+$476K

Top Sells

Rank Stock Value
1
WMS icon
Advanced Drainage Systems
WMS
+$487K
2
PHIN icon
Phinia Inc
PHIN
+$482K
3
VC icon
Visteon
VC
+$476K
4
THC icon
Tenet Healthcare
THC
+$465K
5
PACS icon
PACS Group
PACS
+$456K

Sector Composition

Rank Sector Weight
1 Industrials 25.45%
2 Technology 23.32%
3 Financials 14.23%
4 Consumer Discretionary 11.06%
5 Healthcare 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUOL icon
101
Duolingo
DUOL
$6.3B
$454K 0.44%
1,400
TMHC
102
DELISTED
Taylor Morrison
TMHC
$453K 0.44%
7,400
FSS icon
103
Federal Signal
FSS
$7.71B
$448K 0.43%
4,850
MIDD icon
104
Middleby
MIDD
$5.38B
$447K 0.43%
3,300
PHM icon
105
Pultegroup
PHM
$24.6B
$436K 0.42%
4,000
PAYC icon
106
Paycom
PAYC
$9.52B
$430K 0.41%
2,100
WTM icon
107
White Mountains Insurance
WTM
$5.06B
$428K 0.41%
+220
New +$416K
TS icon
108
Tenaris
TS
$26.8B
$427K 0.41%
11,300
ROAD icon
109
Construction Partners
ROAD
$6.9B
$425K 0.41%
4,800
CAMT icon
110
Camtek
CAMT
$8.13B
$420K 0.4%
5,200
-2,200
-30% -$173K
TDY icon
111
Teledyne Technologies
TDY
$31.8B
$418K 0.4%
900
OVV icon
112
Ovintiv
OVV
$17.5B
$417K 0.4%
10,300
FSV icon
113
FirstService
FSV
$6.24B
$416K 0.4%
2,300
PARR icon
114
Par Pacific Holdings
PARR
$3.9B
$415K 0.4%
+25,300
New +$427K
ELF icon
115
e.l.f. Beauty
ELF
$5.47B
$414K 0.4%
3,300
DGII icon
116
Digi International
DGII
$3.23B
$414K 0.4%
13,700
CHDN icon
117
Churchill Downs
CHDN
$6.17B
$414K 0.4%
3,100
PPC icon
118
Pilgrim's Pride
PPC
$6.4B
$409K 0.39%
9,000
STLD icon
119
Steel Dynamics
STLD
$37.7B
$405K 0.39%
3,550
BLD
120
DELISTED
TopBuild
BLD
$405K 0.39%
1,300
PAX icon
121
Patria Investments
PAX
$1.79B
$395K 0.38%
+34,000
New +$402K
OWL icon
122
Blue Owl Capital
OWL
$19.1B
$393K 0.38%
16,900
SPXC icon
123
SPX Corp
SPXC
$10.9B
$393K 0.38%
2,700
NBIX icon
124
Neurocrine Biosciences
NBIX
$15.9B
$389K 0.37%
2,850
LSTR icon
125
Landstar System
LSTR
$6.31B
$387K 0.37%
2,250

Similar funds

Yorktown Management & Research Company's Q4 2024 Portfolio in Review

As of Q4 2024, Yorktown Management & Research Company held 225 positions worth $104M, up 6.6% from $97.6M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Yorktown Management & Research Company deployed $4.73M of net new capital in Q4 2024, opening 31 new positions and adding to 7 existing holdings. Its largest new stake was Hawkins: 5,150 shares worth $632K.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was The Ensign Group, an estimated $443K trimmed.

  • Yorktown Management & Research Company's largest Q4 2024 buy was Hawkins: 5,150 shares worth $632K.
  • Yorktown Management & Research Company added most to Pampa Energía in Q4 2024, an estimated $433K increase.
  • Yorktown Management & Research Company's biggest Q4 2024 reduction was The Ensign Group, cutting an estimated $443K.
  • Yorktown Management & Research Company fully exited Advanced Drainage Systems in Q4 2024, selling an estimated $487K.
  • Yorktown Management & Research Company's ten largest holdings make up 13% of its $104M portfolio in Q4 2024.
  • Yorktown Management & Research Company opened 31 new positions and closed 21 in Q4 2024.
  • Yorktown Management & Research Company's portfolio value rose 6.6% quarter-over-quarter to $104M.

Based on Yorktown Management & Research Company's 13F filing for Q4 2024, filed 27 Jan 2025.